Page 4 - Restricted Use News Today

The vaccine development data will be submitted to peer-reviewed journals,

Bharat Biotech has secured approval from CDSCO under Restricted Use in Emergency Situation for its intranasal Covid-19 vaccine, iNCOVACC.

A research published in mBio, an open access journal of the American Society for Microbiology last month showed that a needle-free mucosal bacteriophage-based COVID-19 vaccine is effective against SARS-CoV-2 infection.

Food and Drug Administration t issued warning letters to four companies for illegally selling honey-based products that could pose a significant health risk to consumers due to the presence of active drug ingredients Cialis and Viagra not listed on the product labels.

/PRNewswire/ -- As Nebraska farmers brace for high corn rootworm (CRW) pressure following a major resurgence in the Corn Belt in 2021, Golden Harvest is...

Farmers who implement an integrated control program can stay ahead of Colorado potato beetle and other insects that challenge their high yield goa...

China’s State Administration for Market Regulation released the State Administration for Market Regulation on Printing and Distributing Notice of Legislative Work Plan for 2022, which includes intellectual property laws and administrative regulations.

The Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for children of different age groups.The DCGI gave the restricted emergency use authorisation to Bharat ...

/PRNewswire/ -- The "Diagnostic Specialty Antibodies Market by Type, Clonality, Technique, Conjugate, and Application - Forecast to 2029" report has been added...

The Drugs Controller General of India has granted Bharat Biotech the permission to use Covaxin for those aged 6 to 12 years.